Mangalam Drugs surges on getting WHO-Geneva nod for plant at Vapi

25 May 2017 Evaluate

Mangalam Drugs & Organics is currently trading at Rs. 168.80, up by 3.15 points or 1.90% from its previous closing of Rs. 165.65 on the BSE.

The scrip opened at Rs. 171.90 and has touched a high and low of Rs. 172.00 and Rs. 165.70 respectively. So far 18497 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 214.85 on 25-Apr-2017 and a 52 week low of Rs. 122.90 on 22-Nov-2016.

Last one week high and low of the scrip stood at Rs. 184.60 and Rs. 164.95 respectively. The current market cap of the company is Rs. 267.50 crore.

The promoters holding in the company stood at 50.76%, while Institutions and Non-Institutions held 0.19% and 49.05% respectively.

Mangalam Drugs & Organics, one of the leading Pharma/API Company has received the final approval from WHO-Geneva for its plant at Unit-2 situated at G.I.D.C, Vapi, in the state of Gujarat.

Mangalam Drugs & Organics is a part of the MangalamGroup, manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base.

Mangalam Drugs&Org. Share Price

106.90 2.10 (2.00%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.